Here’s what you should know:
1. Case Western researchers are investigating Barrett’s Esophagus’ genetic determinants and esophageal adenocarcinoma.
2. The new grant is an extension of a 2011 grant Case Western received to investigate genetic biomarkers related to the condition.
3. Amitabh Chak, MD, will lead the research. He directs clinical research at UH Cleveland Medical Center.
4. Dr. Chak said in a release, “A non-endoscopic, easy method for identifying Barrett’s Esophagus will result in prevention or early detection of esophageal cancer. Characterizing molecular mechanisms that cause cancer will lead to better targeted approaches [for] effective cancer treatments.”
More articles on gastroenterology:
Screening colonoscopy complication rates low, study says — 3 notes
Physicians Endoscopy purchases stake in Great South Bay Endoscopy & more: 5 GI practices in the news
GI leader to know: Dr. Ronald Feldman
